(Press-News.org) Barcelona, Spain: Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later.
Presenting these results at the 3rd ESTRO Forum in Barcelona, Spain, today (Monday) Professor James Morris, from the Department of Radiation Oncology, Vancouver Cancer Centre, British Columbia Cancer Agency (BCCA), Vancouver, Canada, will say that the ASCENDE-RT1 trial is the first and only existing trial comparing low-dose-rate prostate brachytherapy (LDR-PB) for the curative treatment of prostate cancer with any other method of radiation therapy delivery.
The trial enrolled 398 men with cancer that had not spread outside the prostate gland who were judged to be at high risk of treatment failure, based on standard tests for a number of features of the cancer. The patients initially received androgen deprivation therapy (ADT), aimed at reducing levels of the male hormones that stimulate prostate cancer cells to grow. After eight months of ADT, all patients received 46 Gy2 of external beam radiotherapy to the prostate and regional lymph nodes.
Following this, 198 men received LDR-PB in which tiny radioactive seeds were implanted in the prostate gland while under general or spinal anaesthesia. The other 200 patients were randomised to dose-escalated external beam radiation therapy (DE-EBRT) and received an additional 32 Gy of external beam radiation to achieve a total prostate dose of 78 Gy.
"At five years follow up, we saw a large advantage in progression-free survival in the LDR-PB group," Prof Morris will say. "Although, to date, overall survival and prostate cancer-specific survival do not appear to differ between the two groups, existing trends favour LDR-PB and an overall survival advantage is likely to emerge with longer follow-up."
LDR-PB is an extremely cost-effective treatment, the researchers say, but it does require prolonged training and experience in order to produce consistent results, and this may limit more widespread adoption. An additional problem is that, in the trial, the LDR-PB patients experienced more urinary side effects that those who received DE-EBRT. In a separate presentation Prof Morris's Clinical Research Fellow, Dr Sree Rodda, told the conference that the incidence of severe late urinary side effects was three times higher in patients who received LDR-PB than in those who had DE-EBRT. "Many of these severe adverse effects were temporary and reversible, or could be ameliorated by procedures. Moreover, more than 80% of patients in the LDR-PB arm had few or no long term urinary side effects." However, he says, "the long-term prevalence of severe urinary toxicity in the LDR-PB patients was 8% compared to just 2% for the DE-EBRT patients. An important challenge for the future will be the reduction of these adverse effects while maintaining the advantages of LDR-PB."
At BCCA's five cancer centres, LDR-PB boost is now regarded as the standard of care for unfavourable risk localised prostate cancer. "The ideal next step," Prof Morris will say, "would be to undertake randomised comparisons of LDR-PB boost against its principal alternatives - temporary high-dose-rate brachytherapy implants (HDR-PB)3, stereotactic body radiation therapy using extreme hypofractionation4, and combined surgery and post-operative radiation therapy.
"In the meantime, ASCENDE-RT has made an important contribution to the search for a more effective curative treatment for prostate cancer," he will conclude.
Professor Philip Poortmans, President of ESTRO, commented: "This study illustrates very nicely how the best results can be obtained by combining various treatment options instead of trying to get the most out of one single modality. Brachytherapy is an extremely efficient and safe radiation oncology modality, and this trial shows that it can have a wider field of applicability than simply in very localised and low risk tumours when combined with other techniques - in this case, androgen deprivation therapy and external bean radiation therapy."
INFORMATION:
1. Androgen Suppression Combined with Elective Nodal and Dose Escanodal and Dose Escalated Radiation Therapy.
2. A Gray, or Gy, is a measure of radiation dose, defined as the absorption of one joule of energy per kilogram of tissue.
3. A radiation treatment using temporary implants to deliver high-dose-rate brachytherapy.
4. A form of external beam radiation therapy that delivers a few very large fractions of radiation using new high precision technology.
5. The research was funded entirely by unrestricted educational grants to the BCCA from:
Oncura Corporation (a subsidiary of GE Healthcare and the manufacturer of the radioactive seeds used in the trial).
Sanofi-Aventis, Canada (the maker of the Suprefact and Eligard anti-androgen injections used in the trial).
Barcelona, Spain: Radiotherapy using protons can deliver more accurate treatment to a tumour while reducing the dose to surrounding tissue. However, in mobile organs such as the lung, precise targeting of the dose is difficult. Now researchers have succeeded in making a model of breathing movement that allows for the precise measurement of narrow beams to a dummy tumour by simulating the motion and physical properties of the chest anatomy in a model, the 3rd ESTRO Forum in Barcelona, Spain, will hear today (Monday).
Dr Rosalind Perrin, from the Centre for Proton Therapy ...
Millions of people are dying from common, easily treatable conditions like appendicitis, fractures, or obstructed labour because they do not have access to, or can't afford, proper surgical care, according to a major new Commission, published in The Lancet.
The Commission reveals that five billion people worldwide do not have access to safe and affordable surgery and anaesthesia when they need it, and access is worst in low-income and lower-middle income countries, where as many as nine out of ten people cannot access basic surgical care.
Just under a third of all deaths ...
The team led by Dr Sheena Cruickshank of the Faculty of Life Sciences and Professor Andy Brass from the School of Computer Science analysed 58 papers on research into inflammatory bowel disease published between 2000 and 2014. They found a wide variety in how methods were reported and that vital information about experiments were missing, meaning they couldn't be accurately reproduced in animal or human models.
In several instances the gender of the animal used wasn't recorded which can have a bearing on the result as female mice have a stronger immune response to males. ...
SAN DIEGO - New research shows that it doesn't take much for kids to be considered couch potatoes.
Kindergartners and first-graders who watched as little as one hour of television a day were more likely to be overweight or obese compared to children who watched TV for less than 60 minutes each day, according to a study to be presented Sunday, April 26 at the Pediatric Academic Societies (PAS) annual meeting in San Diego.
Efforts to fight the childhood obesity epidemic have focused on getting kids to be more active. Previous studies have shown that children who watch ...
SAN DIEGO - Adults can have a bigger influence on youths growing up in poor, violent neighborhoods than they may realize, according to a study to be presented Sunday, April 26 at the Pediatric Academic Societies (PAS) annual meeting in San Diego.
Researchers found that males living in Philadelphia who identified supportive relationships with parents and other adult family members were significantly less likely to report that they were involved in violence or had witnessed violence.
"This is good news. In neighborhoods with high levels of community violence and few ...
SAN DIEGO - Since it's nearly impossible to keep mobile devices out of the hands of children, they might as well learn something worthwhile using these devices. That was the idea behind the development of a game app to teach youngsters about bicycle and dog bite safety.
Researchers will present the results of a study looking at the effectiveness of the app on Sunday, April 26 at the Pediatric Academic Societies (PAS) annual meeting in San Diego.
"Despite recommendations for children to have limited screen time, the reality is young children are using mobile devices, ...
SAN DIEGO - Teens no longer smoke just cigarettes. They have branched out to using alternative tobacco products such as electronic cigarettes, hookahs and little cigars. In fact, e-cigarette use is rising rapidly among both cigarette smokers and nonsmokers, according to a study to be presented Sunday, April 26 at the Pediatric Academic Societies (PAS) annual meeting in San Diego.
"Electronic cigarettes are of great concern. They are highly addictive nicotine delivery devices, and the vapor can and does cause harm to lungs," said principal investigator Jonathan D. Klein, ...
SAN DIEGO - When schools close their doors for the summer, many low-income children who rely on subsidized breakfasts and lunches don't know when they will get their next meal. An innovative program to fill this gap could serve as a model for communities looking to help feed struggling families when school is out.
Results of a study evaluating the impact of the summer feeding program will be presented on Sunday, April 26 at the Pediatric Academic Societies (PAS) annual meeting in San Diego.
In early 2012, Lisa Chamberlain, MD, MPH, FAAP, a pediatrician at a community ...
SAN DIEGO - Smartphones and tablets have become part of everyday life, but parents still worry that mobile devices may not be the best thing for their children, according to a study to be presented Sunday, April 26 at the Pediatric Academic Societies (PAS) annual meeting in San Diego.
The scientific literature has not kept pace with how technology is affecting family life. To help fill this gap, researchers conducted in-depth interviews with 35 parents/guardians to learn about their views regarding mobile device use by themselves and their children, including benefits, ...
SAN DIEGO - About one in 14 toddlers diagnosed with autism spectrum disorder (ASD) no longer met the diagnostic criteria in elementary school, but most continued to have emotional/behavior symptoms and required special education supports, according to a study to be presented Sunday, April 26 at the Pediatric Academic Societies (PAS) annual meeting in San Diego.
Previous studies have shown that ASD symptoms resolve in some children over time. It is not clear, however, if these children continue to have cognitive, behavioral or learning deficits.
Researchers, led by ...
